Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Co-development partnering allow the parties to securitize value and reduce risk, but keep a part of the potential upside should the product reach the market. Event if the licensor does not commercialize the project they can either sell those rights to the licensee partner or another partner for an amount higher than would have been achieved at an earlier stage licensing deal.
Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Industry sector and Therapy areas are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
1ST Biotherapeutics
3B Pharmaceuticals
3D-Micromac
3DMed
3D Systems
10X Genomics
A*STAR Agency for Science
Technology and Research
A*STAR Institute of Microelectronics (IME)
A2A Pharmaceuticals
Abbvie
AbCellera
ABL Bio
Abpro
Academy of Military Medical Sciences (China)
Accellix
Accord Healthcare
AccuGenomics
ACEA Biosciences
AC Immune
Acoustic MedSystems
Adaptimmune
Aduro BioTech
Advaxis
Adventus Ventures
Aerolase
Segment by Type
Asset purchase
Assignment
Co-development
Co-market
Co-promotion
Collaborative R&D
Contract service
CRADA
Cross-licensing
Others
Segment by Application
Industry sector
Therapy areas
Technology type
Deal components
Financial terms
Stage of development
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics introduction, etc. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Table of Content
1 Market Overview of Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
1.1 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Overview
1.1.1 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Scope
1.1.2 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Status and Outlook
1.2 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Region (2018-2033)
1.4 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (2018-2033)
1.6.1 North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (2018-2033)
1.6.2 Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (2018-2033)
1.6.3 Asia-Pacific Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (2018-2033)
1.6.4 Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (2018-2033)
1.6.5 Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (2018-2033)
2 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market by Type
2.1 Introduction
2.1.1 Asset purchase
2.1.2 Assignment
2.1.3 Co-development
2.1.4 Co-market
2.1.5 Co-promotion
2.1.6 Collaborative R&D
2.1.7 Contract service
2.1.8 CRADA
2.1.9 Cross-licensing
2.1.10 Others
2.2 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Breakdown by Type (2018-2033)
3 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Industry sector
3.1.2 Therapy areas
3.1.3 Technology type
3.1.4 Deal components
3.1.5 Financial terms
3.1.6 Stage of development
3.1.7 Others
3.2 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Breakdown by Application (2018-2033)
4 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Competition Analysis by Players
4.1 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics as of 2022)
4.3 Date of Key Players Enter into Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market
4.4 Global Top Players Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Headquarters and Area Served
4.5 Key Players Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 1ST Biotherapeutics
5.1.1 1ST Biotherapeutics Profile
5.1.2 1ST Biotherapeutics Main Business
5.1.3 1ST Biotherapeutics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
5.1.4 1ST Biotherapeutics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 1ST Biotherapeutics Recent Developments
5.2 3B Pharmaceuticals
5.2.1 3B Pharmaceuticals Profile
5.2.2 3B Pharmaceuticals Main Business
5.2.3 3B Pharmaceuticals Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
5.2.4 3B Pharmaceuticals Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 3B Pharmaceuticals Recent Developments
5.3 3D-Micromac
5.3.1 3D-Micromac Profile
5.3.2 3D-Micromac Main Business
5.3.3 3D-Micromac Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
5.3.4 3D-Micromac Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 3DMed Recent Developments
5.4 3DMed
5.4.1 3DMed Profile
5.4.2 3DMed Main Business
5.4.3 3DMed Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
5.4.4 3DMed Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 3DMed Recent Developments
5.5 3D Systems
5.5.1 3D Systems Profile
5.5.2 3D Systems Main Business
5.5.3 3D Systems Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
5.5.4 3D Systems Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 3D Systems Recent Developments
5.6 10X Genomics
5.6.1 10X Genomics Profile
5.6.2 10X Genomics Main Business
5.6.3 10X Genomics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
5.6.4 10X Genomics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 10X Genomics Recent Developments
5.7 A*STAR Agency for Science
5.7.1 A*STAR Agency for Science Profile
5.7.2 A*STAR Agency for Science Main Business
5.7.3 A*STAR Agency for Science Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
5.7.4 A*STAR Agency for Science Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 A*STAR Agency for Science Recent Developments
5.8 Technology and Research
5.8.1 Technology and Research Profile
5.8.2 Technology and Research Main Business
5.8.3 Technology and Research Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
5.8.4 Technology and Research Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue (US$ Million) & (2018-2023)
5.8.5 Technology and Research Recent Developments
5.9 A*STAR Institute of Microelectronics (IME)
5.9.1 A*STAR Institute of Microelectronics (IME) Profile
5.9.2 A*STAR Institute of Microelectronics (IME) Main Business
5.9.3 A*STAR Institute of Microelectronics (IME) Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
5.9.4 A*STAR Institute of Microelectronics (IME) Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue (US$ Million) & (2018-2023)
5.9.5 A*STAR Institute of Microelectronics (IME) Recent Developments
5.10 A2A Pharmaceuticals
5.10.1 A2A Pharmaceuticals Profile
5.10.2 A2A Pharmaceuticals Main Business
5.10.3 A2A Pharmaceuticals Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
5.10.4 A2A Pharmaceuticals Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue (US$ Million) & (2018-2023)
5.10.5 A2A Pharmaceuticals Recent Developments
5.11 Abbvie
5.11.1 Abbvie Profile
5.11.2 Abbvie Main Business
5.11.3 Abbvie Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
5.11.4 Abbvie Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue (US$ Million) & (2018-2023)
5.11.5 Abbvie Recent Developments
5.12 AbCellera
5.12.1 AbCellera Profile
5.12.2 AbCellera Main Business
5.12.3 AbCellera Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
5.12.4 AbCellera Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue (US$ Million) & (2018-2023)
5.12.5 AbCellera Recent Developments
5.13 ABL Bio
5.13.1 ABL Bio Profile
5.13.2 ABL Bio Main Business
5.13.3 ABL Bio Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
5.13.4 ABL Bio Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue (US$ Million) & (2018-2023)
5.13.5 ABL Bio Recent Developments
5.14 Abpro
5.14.1 Abpro Profile
5.14.2 Abpro Main Business
5.14.3 Abpro Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
5.14.4 Abpro Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue (US$ Million) & (2018-2023)
5.14.5 Abpro Recent Developments
5.15 Academy of Military Medical Sciences (China)
5.15.1 Academy of Military Medical Sciences (China) Profile
5.15.2 Academy of Military Medical Sciences (China) Main Business
5.15.3 Academy of Military Medical Sciences (China) Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
5.15.4 Academy of Military Medical Sciences (China) Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue (US$ Million) & (2018-2023)
5.15.5 Academy of Military Medical Sciences (China) Recent Developments
5.16 Accellix
5.16.1 Accellix Profile
5.16.2 Accellix Main Business
5.16.3 Accellix Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
5.16.4 Accellix Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue (US$ Million) & (2018-2023)
5.16.5 Accellix Recent Developments
5.17 Accord Healthcare
5.17.1 Accord Healthcare Profile
5.17.2 Accord Healthcare Main Business
5.17.3 Accord Healthcare Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
5.17.4 Accord Healthcare Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue (US$ Million) & (2018-2023)
5.17.5 Accord Healthcare Recent Developments
5.18 AccuGenomics
5.18.1 AccuGenomics Profile
5.18.2 AccuGenomics Main Business
5.18.3 AccuGenomics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
5.18.4 AccuGenomics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue (US$ Million) & (2018-2023)
5.18.5 AccuGenomics Recent Developments
5.19 ACEA Biosciences
5.19.1 ACEA Biosciences Profile
5.19.2 ACEA Biosciences Main Business
5.19.3 ACEA Biosciences Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
5.19.4 ACEA Biosciences Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue (US$ Million) & (2018-2023)
5.19.5 ACEA Biosciences Recent Developments
5.20 AC Immune
5.20.1 AC Immune Profile
5.20.2 AC Immune Main Business
5.20.3 AC Immune Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
5.20.4 AC Immune Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue (US$ Million) & (2018-2023)
5.20.5 AC Immune Recent Developments
5.21 Acoustic MedSystems
5.21.1 Acoustic MedSystems Profile
5.21.2 Acoustic MedSystems Main Business
5.21.3 Acoustic MedSystems Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
5.21.4 Acoustic MedSystems Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue (US$ Million) & (2018-2023)
5.21.5 Acoustic MedSystems Recent Developments
5.22 Adaptimmune
5.22.1 Adaptimmune Profile
5.22.2 Adaptimmune Main Business
5.22.3 Adaptimmune Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
5.22.4 Adaptimmune Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue (US$ Million) & (2018-2023)
5.22.5 Adaptimmune Recent Developments
5.23 Aduro BioTech
5.23.1 Aduro BioTech Profile
5.23.2 Aduro BioTech Main Business
5.23.3 Aduro BioTech Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
5.23.4 Aduro BioTech Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue (US$ Million) & (2018-2023)
5.23.5 Aduro BioTech Recent Developments
5.24 Advaxis
5.24.1 Advaxis Profile
5.24.2 Advaxis Main Business
5.24.3 Advaxis Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
5.24.4 Advaxis Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue (US$ Million) & (2018-2023)
5.24.5 Advaxis Recent Developments
5.25 Adventus Ventures
5.25.1 Adventus Ventures Profile
5.25.2 Adventus Ventures Main Business
5.25.3 Adventus Ventures Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
5.25.4 Adventus Ventures Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue (US$ Million) & (2018-2023)
5.25.5 Adventus Ventures Recent Developments
5.26 Aerolase
5.26.1 Aerolase Profile
5.26.2 Aerolase Main Business
5.26.3 Aerolase Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
5.26.4 Aerolase Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue (US$ Million) & (2018-2023)
5.26.5 Aerolase Recent Developments
6 North America
6.1 North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2018-2033)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Dynamics
11.1 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Industry Trends
11.2 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Drivers
11.3 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Challenges
11.4 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Figure
List of Tables
Table 1. Global Market Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Share by Region (2018-2023)
Table 4. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Market Share by Type (2018-2023)
Table 9. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Market Share by Type (2024-2033)
Table 11. North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Market Share by Application (2018-2023)
Table 24. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Market Share by Application (2024-2033)
Table 26. North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics as of 2022)
Table 39. Date of Key Players Enter into Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market
Table 40. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Key Players Headquarters and Area Served
Table 41. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Solution and Service
Table 42. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. 1ST Biotherapeutics Basic Information List
Table 45. 1ST Biotherapeutics Description and Business Overview
Table 46. 1ST Biotherapeutics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 47. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of 1ST Biotherapeutics (2018-2023)
Table 48. 1ST Biotherapeutics Recent Developments
Table 49. 3B Pharmaceuticals Basic Information List
Table 50. 3B Pharmaceuticals Description and Business Overview
Table 51. 3B Pharmaceuticals Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 52. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of 3B Pharmaceuticals (2018-2023)
Table 53. 3B Pharmaceuticals Recent Developments
Table 54. 3D-Micromac Basic Information List
Table 55. 3D-Micromac Description and Business Overview
Table 56. 3D-Micromac Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 57. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of 3D-Micromac (2018-2023)
Table 58. 3D-Micromac Recent Developments
Table 59. 3DMed Basic Information List
Table 60. 3DMed Description and Business Overview
Table 61. 3DMed Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 62. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of 3DMed (2018-2023)
Table 63. 3DMed Recent Developments
Table 64. 3D Systems Basic Information List
Table 65. 3D Systems Description and Business Overview
Table 66. 3D Systems Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 67. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of 3D Systems (2018-2023)
Table 68. 3D Systems Recent Developments
Table 69. 10X Genomics Basic Information List
Table 70. 10X Genomics Description and Business Overview
Table 71. 10X Genomics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 72. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of 10X Genomics (2018-2023)
Table 73. 10X Genomics Recent Developments
Table 74. A*STAR Agency for Science Basic Information List
Table 75. A*STAR Agency for Science Description and Business Overview
Table 76. A*STAR Agency for Science Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 77. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of A*STAR Agency for Science (2018-2023)
Table 78. A*STAR Agency for Science Recent Developments
Table 79. Technology and Research Basic Information List
Table 80. Technology and Research Description and Business Overview
Table 81. Technology and Research Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 82. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of Technology and Research (2018-2023)
Table 83. Technology and Research Recent Developments
Table 84. A*STAR Institute of Microelectronics (IME) Basic Information List
Table 85. A*STAR Institute of Microelectronics (IME) Description and Business Overview
Table 86. A*STAR Institute of Microelectronics (IME) Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 87. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of A*STAR Institute of Microelectronics (IME) (2018-2023)
Table 88. A*STAR Institute of Microelectronics (IME) Recent Developments
Table 89. A2A Pharmaceuticals Basic Information List
Table 90. A2A Pharmaceuticals Description and Business Overview
Table 91. A2A Pharmaceuticals Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 92. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of A2A Pharmaceuticals (2018-2023)
Table 93. A2A Pharmaceuticals Recent Developments
Table 94. Abbvie Basic Information List
Table 95. Abbvie Description and Business Overview
Table 96. Abbvie Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 97. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of Abbvie (2018-2023)
Table 98. Abbvie Recent Developments
Table 99. AbCellera Basic Information List
Table 100. AbCellera Description and Business Overview
Table 101. AbCellera Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 102. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of AbCellera (2018-2023)
Table 103. AbCellera Recent Developments
Table 104. ABL Bio Basic Information List
Table 105. ABL Bio Description and Business Overview
Table 106. ABL Bio Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 107. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of ABL Bio (2018-2023)
Table 108. ABL Bio Recent Developments
Table 109. Abpro Basic Information List
Table 110. Abpro Description and Business Overview
Table 111. Abpro Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 112. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of Abpro (2018-2023)
Table 113. Abpro Recent Developments
Table 114. Academy of Military Medical Sciences (China) Basic Information List
Table 115. Academy of Military Medical Sciences (China) Description and Business Overview
Table 116. Academy of Military Medical Sciences (China) Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 117. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of Academy of Military Medical Sciences (China) (2018-2023)
Table 118. Academy of Military Medical Sciences (China) Recent Developments
Table 119. Accellix Basic Information List
Table 120. Accellix Description and Business Overview
Table 121. Accellix Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 122. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of Accellix (2018-2023)
Table 123. Accellix Recent Developments
Table 124. Accord Healthcare Basic Information List
Table 125. Accord Healthcare Description and Business Overview
Table 126. Accord Healthcare Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 127. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of Accord Healthcare (2018-2023)
Table 128. Accord Healthcare Recent Developments
Table 129. AccuGenomics Basic Information List
Table 130. AccuGenomics Description and Business Overview
Table 131. AccuGenomics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 132. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of AccuGenomics (2018-2023)
Table 133. AccuGenomics Recent Developments
Table 134. ACEA Biosciences Basic Information List
Table 135. ACEA Biosciences Description and Business Overview
Table 136. ACEA Biosciences Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 137. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of ACEA Biosciences (2018-2023)
Table 138. ACEA Biosciences Recent Developments
Table 139. AC Immune Basic Information List
Table 140. AC Immune Description and Business Overview
Table 141. AC Immune Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 142. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of AC Immune (2018-2023)
Table 143. AC Immune Recent Developments
Table 144. Acoustic MedSystems Basic Information List
Table 145. Acoustic MedSystems Description and Business Overview
Table 146. Acoustic MedSystems Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 147. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of Acoustic MedSystems (2018-2023)
Table 148. Acoustic MedSystems Recent Developments
Table 149. Adaptimmune Basic Information List
Table 150. Adaptimmune Description and Business Overview
Table 151. Adaptimmune Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 152. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of Adaptimmune (2018-2023)
Table 153. Adaptimmune Recent Developments
Table 154. Aduro BioTech Basic Information List
Table 155. Aduro BioTech Description and Business Overview
Table 156. Aduro BioTech Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 157. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of Aduro BioTech (2018-2023)
Table 158. Aduro BioTech Recent Developments
Table 159. Advaxis Basic Information List
Table 160. Advaxis Description and Business Overview
Table 161. Advaxis Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 162. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of Advaxis (2018-2023)
Table 163. Advaxis Recent Developments
Table 164. Adventus Ventures Basic Information List
Table 165. Adventus Ventures Description and Business Overview
Table 166. Adventus Ventures Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 167. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of Adventus Ventures (2018-2023)
Table 168. Adventus Ventures Recent Developments
Table 169. Aerolase Basic Information List
Table 170. Aerolase Description and Business Overview
Table 171. Aerolase Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Products, Services and Solutions
Table 172. Revenue (US$ Million) in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business of Aerolase (2018-2023)
Table 173. Aerolase Recent Developments
Table 174. North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 175. North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 176. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 177. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 178. Asia-Pacific Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 179. Asia-Pacific Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 180. Asia-Pacific Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Region (2024-2033) & (US$ Million)
Table 181. Asia-Pacific Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Region (2018-2023)
Table 182. Asia-Pacific Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Region (2024-2033)
Table 183. Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 184. Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 185. Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 186. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 187. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 188. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 189. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Trends
Table 190. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Drivers
Table 191. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Challenges
Table 192. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Regions: 2022 VS 2033
Figure 4. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Asset purchase
Figure 11. Global Asset purchase Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Assignment
Figure 13. Global Assignment Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Product Picture of Co-development
Figure 15. Global Co-development Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 16. Product Picture of Co-market
Figure 17. Global Co-market Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 18. Product Picture of Co-promotion
Figure 19. Global Co-promotion Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 20. Product Picture of Collaborative R&D
Figure 21. Global Collaborative R&D Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 22. Product Picture of Contract service
Figure 23. Global Contract service Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 24. Product Picture of CRADA
Figure 25. Global CRADA Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 26. Product Picture of Cross-licensing
Figure 27. Global Cross-licensing Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 28. Product Picture of Others
Figure 29. Global Others Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 30. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Share by Type: 2022 & 2033
Figure 31. North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Market Share by Type (2018-2033)
Figure 32. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Market Share by Type (2018-2033)
Figure 33. Asia-Pacific Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Market Share by Type (2018-2033)
Figure 34. Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Market Share by Type (2018-2033)
Figure 35. Middle East and Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Market Share by Type (2018-2033)
Figure 36. Industry sector Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 37. Therapy areas Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 38. Technology type Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 39. Deal components Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 40. Financial terms Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 41. Stage of development Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 42. Others Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 43. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Share by Application: 2022 & 2033
Figure 44. North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Market Share by Application (2018-2033)
Figure 45. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Market Share by Application (2018-2033)
Figure 46. Asia-Pacific Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Market Share by Application (2018-2033)
Figure 47. Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Market Share by Application (2018-2033)
Figure 48. Middle East and Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Market Share by Application (2018-2033)
Figure 49. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 50. Global Top 5 and Top 10 Players Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share in 2022
Figure 51. North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Country (2018-2033)
Figure 52. United States Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (2018-2033) & (US$ Million)
Figure 53. Canada Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (2018-2033) & (US$ Million)
Figure 54. Germany Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (2018-2033) & (US$ Million)
Figure 55. France Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (2018-2033) & (US$ Million)
Figure 56. U.K. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (2018-2033) & (US$ Million)
Figure 57. Italy Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (2018-2033) & (US$ Million)
Figure 58. Russia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (2018-2033) & (US$ Million)
Figure 59. Nordic Countries Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (2018-2033) & (US$ Million)
Figure 60. Asia-Pacific Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Region (2018-2033)
Figure 61. China Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (2018-2033) & (US$ Million)
Figure 62. Japan Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (2018-2033) & (US$ Million)
Figure 63. South Korea Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (2018-2033) & (US$ Million)
Figure 64. Southeast Asia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (2018-2033) & (US$ Million)
Figure 65. India Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (2018-2033) & (US$ Million)
Figure 66. Australia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (2018-2033) & (US$ Million)
Figure 67. Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Country (2018-2033)
Figure 68. Mexico Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (2018-2033) & (US$ Million)
Figure 69. Brazil Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (2018-2033) & (US$ Million)
Figure 70. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Country (2018-2033)
Figure 71. Turkey Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (2018-2033) & (US$ Million)
Figure 72. Saudi Arabia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (2018-2033) & (US$ Million)
Figure 73. UAE Co-development Partnering Terms and Agreements in P
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices